Skip to content

Clinical Trial To Study The Anti-scarring Effect Of Cicatricell

Clinical Trial To Study The Anti-scarring Effect Of Cicatricell

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03020420
Acronym
Cicatricell
Enrollment
52
Registered
2017-01-13
Start date
2015-03-31
Completion date
2020-12-31
Last updated
2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Incisions

Brief summary

This study tries to prove that Cicatricell cream significantly reduces scarring with better wound appearance as compared to no treatment.

Detailed description

At 1st post operative follow up visit, surgical incision(s) will be assessed for healing, after the sutures/staples/steri-strips are removed. To be included in the study the incision must be 5cm or greater. And bilateral incisions as in bilateral mastectomy can be included. The incisions will be divided into two sections, using an imaginary line between top and bottom, or left and right. One side of the imaginary line will have cicatricell cream applied 2 times a day for a minimum of 8 weeks and a maximum 6months. The other side of the imaginary line will remain untreated. In the case of a bilateral incision, as in bilateral breast mastectomy or AAA incisions in the groins, the cream will be applied to one entire incision and the 2nd incision will be untreated. The incision(s) will be its own control group. At the end of the treatment phase the incision(s) will be assessed again to compare the healing.

Interventions

OTHERCicatricell Cream

Cream to be applied 2 times a day for 8weeks to 6 months

Sponsors

University of Toledo Health Science Campus
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Signed IRB approved, written informed consent. * Patient from 18 to 60 years of age. * Patient who recently underwent a surgery involving linear surgical skin incisions of 5cm or more or patients with two exactly symmetrical separate incisions like bilateral inguinal hernia repair or bilateral mastectomy, CT surgery patients will be included.

Exclusion criteria

* Known skin allergies.

Design outcomes

Primary

MeasureTime frameDescription
Improved wound appearance8 weeks to 6 monthsimproved wound appearance by surface area measurement
improved wound appearance8 weeks to 6 monthswound indentation measurement with caliper
Modified Vancouver Scar Scale8 weeks to 6 monthsa scale of visual assessment of a scar
Manchester Scar Scale8 weeks to 6 monthsA new quantitative scale for clinical scar assessment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026